Edgewell to Drive Supply Chain Efficiency With Digital Optimization
Edgewell Personal Care Co. is implementing a supply chain optimization strategy focused on digital tools and automation to improve efficiency, accelerate decision-making, and achieve productivity savings. This effort follows a strategic review and leadership restructuring, with an emphasis on its North American wet shave business and strengthening five key brands. The company expects these optimizations to offset tariff pressures, reduce complexity, and increase service levels.
Analysts Offer Insights on Consumer Goods Companies: Edgewell Personal Care (EPC) and Target (TGT)
Analysts have provided new ratings for Edgewell Personal Care (EPC) and Target (TGT) within the Consumer Goods sector. Morgan Stanley maintained a Hold rating on Edgewell Personal Care with a $21.00 price target, while Guggenheim upheld a Buy rating on Target with a $125.00 price target. The consensus for Edgewell Personal Care is a Moderate Buy, and for Target, it's a Hold.
Edgewell Personal Care tops Q1 forecasts, finalizes exit from feminine care
Edgewell Personal Care (EPC) exceeded its Q1 revenue and earnings forecasts, driven by strong performance across its portfolio, particularly in sun care. The company also announced the finalization of its exit from the feminine care category in the U.S. and Canada, with its shares rising in pre-market trading.
Edgewell Personal Care's (NYSE:EPC) Soft Earnings Don't Show The Whole Picture
Despite seemingly soft earnings, Edgewell Personal Care (NYSE:EPC) shows promising signs, primarily because its reported profits were significantly reduced by US$130 million due to unusual items that are often not repeated. This suggests the company's underlying earnings potential is better than the statutory profit indicates, although its EPS did shrink in the last twelve months. Investors should consider these factors beyond just the headline profit numbers to understand the company's true financial health.
Edgewell Personal Care price target raised to $24 from $22 at Wells Fargo
Wells Fargo has increased its price target for Edgewell Personal Care (EPC) shares to $24 from $22, while maintaining an Overweight rating. This adjustment reflects Wells Fargo's refreshing of price targets for sector moves, noting a strong start for Staples compared to the S&P 500. This news follows previous target increases from Wells Fargo and Barclays for Edgewell Personal Care.
GSA Capital Partners LLP Takes Position in Edgewell Personal Care Company $EPC
GSA Capital Partners LLP initiated a new position in Edgewell Personal Care Company (NYSE:EPC), acquiring 112,451 shares valued at approximately $2.29 million during the third quarter. Institutional investors now hold about 91.91% of the company's stock. Edgewell recently reported mixed Q3 earnings, beating EPS estimates but missing on revenue, and announced a quarterly dividend of $0.15.
Schick class action alleges dermaplaning tools unsafe for at-home use
A class action lawsuit has been filed against Edgewell Personal Care Company and Schick US, alleging that Schick falsely advertises its dermaplaning tools as safe for at-home use. Plaintiffs Jillian Frederick and Ching Yu Yang claim that despite medical warnings that dermaplaning should be performed by professionals, Schick markets the tools for expert at-home care, posing significant risks to consumers. The lawsuit seeks to represent all U.S. purchasers of Schick dermaplaning devices, citing violations of consumer laws, breach of warranty, and breach of contract.
Edgewell Personal Care Co Breaks Above 200-Day Moving Average - Bullish for EPC
Shares of Edgewell Personal Care Co (EPC) have risen above their 200-day moving average of $21.90, reaching $22.16 per share, indicating a bullish trend. The stock's 52-week trading range is $15.88 to $32.96, with the most recent trade at $21.81. This movement above the 200-day moving average is often considered a positive technical indicator for investors.
Edgewell Personal Care's Q4 Earnings Call: Our Top 5 Analyst Questions
Edgewell Personal Care (EPC) reported a challenging Q4 CY2025, missing revenue estimates and seeing a sales decline, which management attributed to international market softness and Sun Care shipment shifts. Despite in-line adjusted EPS, the company lowered its full-year guidance. Analysts' questions focused on portfolio strategy, transition costs, category growth, Sun Care order timing, and promotional activity in Wet Shave, highlighting key areas for future performance monitoring.
Schick class action alleges dermaplaning tools unsafe for at-home use
A class action lawsuit has been filed against Edgewell Personal Care Company and Schick US, alleging that Schick falsely advertises its dermaplaning tools as safe for at-home use. Plaintiffs claim that using these tools without professional supervision poses significant risks, conflicting with medical guidance. The lawsuit seeks to represent all U.S. consumers who purchased Schick’s dermaplaning devices, alleging false advertising, breach of warranty, and breach of contract.
A Look At Edgewell Personal Care (EPC) Valuation After Wider Quarterly Loss And Mixed Insider And Analyst Signals
Edgewell Personal Care (EPC) reported a wider first-quarter net loss of US$65.7 million despite sales of US$422.8 million, leading to mixed signals from analysts and insiders. The stock has seen positive short-term momentum with a 30-day return of 17.25% and a year-to-date return of 29.83%, although longer-term holders have experienced declines. Analysts generally consider the stock undervalued, with a fair value estimate of $23.86 against a closing price of $21.89, suggesting modest upside potential.
Does Edgewell (EPC) Prioritizing Dividends Amid Losses Reveal Its True Capital Allocation Strategy?
Edgewell Personal Care (EPC) reported Q1 2026 results with increased sales but a net loss of US$65.7 million. Despite the loss and halted share repurchases, the company maintained its US$0.15 quarterly dividend, indicating a continued commitment to shareholder returns via cash flow. This strategy highlights a focus on dividends even as profitability faces pressure, raising questions about the sustainability of payouts amidst ongoing financial challenges.
Edgewell Personal Care (NYSE:EPC) Cut to "Sell" at Wall Street Zen
Wall Street Zen has downgraded Edgewell Personal Care (NYSE:EPC) from a "hold" to a "sell" rating. Despite this, the overall analyst consensus remains "Hold" with an average target price of $23.33. The company recently reported mixed quarterly results, with EPS beating estimates but revenue falling short, and institutional investors hold a significant portion of its shares.
Banana Boat sunscreen recalled due to traces of cancer-causing chemical benzene
Edgewell Personal Care Company issued a voluntary nationwide recall of three batches of Banana Boat Hair & Scalp Sunscreen Spray SPF 30. The recall was initiated after an internal review found unexpected levels of benzene, a human carcinogen, in the product. Consumers are advised to stop using the recalled sunscreen immediately and can seek reimbursement from Banana Boat.
Edgewell starts fiscal year 2026 with sales growth and progress in portfolio restructuring
Edgewell Personal Care reported a solid start to fiscal year 2026, with sales growth and significant progress in restructuring its portfolio, notably the divestiture of its feminine care business. The company exceeded expectations for organic net sales, adjusted earnings per share, and adjusted EBITDA, maintaining its full-year outlook despite some pressure on gross margin from cost inflation. This strategic shift aims for sustainable growth, increased industrial efficiency, and a strengthened supply chain in its core categories.
Edgewell Personal Care Company (NYSE:EPC) Analysts Are More Bearish Than They Used To Be
Analysts have revised their forecasts for Edgewell Personal Care Company (NYSE:EPC), lowering revenue and earnings per share estimates for 2026. This downgrade suggests a more bearish outlook due to expected declines in sales and slower growth compared to the wider industry. Despite the negative revisions, the price target remains unchanged, though the article warns investors to be cautious given the deteriorating business conditions.
Edgewell Personal Care Company (NYSE:EPC) Analysts Are More Bearish Than They Used To Be
Analysts have revised down their statutory forecasts for Edgewell Personal Care Company (NYSE:EPC) for the current year, showing a more bearish outlook. Both revenue and earnings per share (EPS) estimates were cut, with revenues now projected to decline by 11% and EPS expected to be US$0.94, a significant drop from previous forecasts. While the price target remained unchanged, the downgrades suggest potential headwinds for the company, with expected revenue growth lagging the industry.
Edgewell Personal Care (EPC) Receives a Buy from RBC Capital
RBC Capital analyst Nik Modi maintained a Buy rating on Edgewell Personal Care (EPC) with a $23.00 price target. This follows the company's latest earnings report showing $422.8 million in quarterly revenue and a GAAP net loss of $65.7 million. Insider sentiment for EPC is negative, with recent selling activity observed.
Edgewell Reaffirms Outlook After Feminine Care Divestiture
Edgewell Personal Care (EPC) has reaffirmed its full-year outlook for continuing operations after completing the $340 million divestiture of its Feminine Care business. Shareholders recently approved amendments to the company's stock incentive plan, re-elected directors, and ratified the auditor, indicating strong support for management. Despite facing inflationary pressures and higher costs, the company's Q1 fiscal 2026 results slightly exceeded expectations, and its recent strategy aims for sustainable growth and shareholder returns.
The Analyst Verdict: Edgewell Personal Care In The Eyes Of 7 Experts
Seven analysts have recently rated Edgewell Personal Care (NYSE: EPC), resulting in an average 12-month price target of $21.29, a 5.67% decrease from the previous average. While the company exhibits positive revenue growth and strong return on equity, its market capitalization, net margin, and return on assets are below industry averages, indicating potential challenges despite its balanced debt management. The diverse analyst ratings and financial insights help provide a comprehensive view of the company's market standing.
Edgewell Personal Care (NYSE:EPC) Trading Up 8% on Better-Than-Expected Earnings
Edgewell Personal Care (NYSE:EPC) saw its shares rise by 8% after announcing better-than-expected quarterly earnings, with GAAP EPS beating consensus estimates. Despite a revenue miss and a cautious FY2026 guidance that is below Street estimates, the company's sentiment was boosted by the sale of its feminine care business and a declared quarterly dividend. Analysts have a mixed outlook, with a consensus "Hold" rating and an average price target of $23.33.
Barclays Raises Price Target for Edgewell Personal Care (EPC)
Barclays has increased its price target for Edgewell Personal Care (EPC) from $19.00 to $21.00, while maintaining an "Equal-Weight" rating. This adjustment reflects a positive revaluation outlook. Despite this, the average target price from six analysts is $22.67, with a consensus "Hold" status, and GuruFocus estimates a one-year GF Value of $41.15 for EPC.
Edgewell Personal Care Company (NYSE:EPC) Q1 2026 earnings call transcript
This document is a transcript of Edgewell Personal Care Company's Q1 2026 earnings call. It provides detailed discussion and insights into the company's financial performance, operational achievements, and future outlook as presented during the call.
Edgewell Personal Care Company (NYSE:EPC) Q1 2026 Earnings Call Transcript
Edgewell Personal Care Company reported its Q1 2026 earnings, exceeding expectations with an EPS of $-0.16 against an anticipated $-0.18. The company highlighted the successful divestiture of its feminine care business, which is expected to favorably impact its financial profile and allow for a sharpened focus on its core categories: Shave, Sun, Skincare, and Grooming.
Canaccord Genuity reiterates Buy rating on Edgewell Personal Care stock
Canaccord Genuity has reiterated its Buy rating and a $32.00 price target on Edgewell Personal Care (NYSE:EPC) following strong Q1 fiscal 2026 results that exceeded analyst expectations. The company demonstrated sales growth and strategic financial maneuvers, including the sale of its Feminine Care business to reduce debt and reinvest, which analysts view as positive for its valuation. Edgewell's solid financial position, reflected in its current ratio and dividend yield, along with an aggressive share buyback program, further underpins the positive outlook.
Edgewell Personal Care (NYSE:EPC) Misses Q4 CY2025 Revenue Estimates
Edgewell Personal Care (NYSE:EPC) reported Q4 CY2025 earnings with consolidated net sales of $486.8 million, exceeding expectations, and a non-GAAP profit of $0.03 per share, significantly beating analyst estimates. Despite the strong quarterly performance, management lowered its full-year Adjusted EPS guidance to $1.90 and EBITDA guidance to $255 million, both below analyst expectations. The company also highlighted the divestiture of its Feminine Care business as a pivotal step in its transformation.
Edgewell Personal Care P/E Premium And 1.1% Margin Reinforce Bearish Earnings Narratives
Edgewell Personal Care (EPC) has opened fiscal 2026 with mixed Q1 results, showing volatile EPS and compressed profit margins of 1.1%. The company's P/E ratio of 36.4x is higher than industry and peer averages, further complicated by a significant one-off loss of US$108.8 million in the last 12 months. While bulls point to a wide gap between the current share price and a DCF fair value of US$46.68, bears emphasize concerns about sustained pressure on profitability, slow revenue growth, and potential overvaluation given the quality of earnings.
Edgewell Personal Care (NYSE:EPC) Misses Q4 CY2025 Revenue Estimates
Edgewell Personal Care (NYSE:EPC) reported Q4 CY2025 revenue of $422.8 million, missing analyst estimates by 11.6% due to an 11.6% year-on-year decline in sales. Despite the revenue miss, the company's non-GAAP EPS of $0.03 significantly beat analyst expectations. Management also lowered its full-year Adjusted EPS and EBITDA guidance, leading to a mixed quarterly performance despite organic revenue being flat.
Edgewell Personal Care Reports Q1 Loss on Divestiture, Updates FY 2026 Outlook
Edgewell Personal Care (NYSE: EPC) reported a GAAP diluted loss per share of $1.41 for its first fiscal quarter, primarily due to the divestiture of its Feminine Care business for $340 million. While organic net sales declined slightly, the Sun and Skin Care segment saw growth, offsetting declines in Wet Shave. The company maintained its full-year organic sales and adjusted earnings guidance, focusing on portfolio simplification and operational agility.
Edgewell Personal Care (NYSE:EPC) Shares Gap Down - Here's Why
Edgewell Personal Care (NYSE:EPC) shares gapped down following its Q1 fiscal 2026 earnings report, despite an EPS beat, due to a significant revenue miss and lower-than-expected FY2026 guidance. The company's Q1 revenue of $422.8M fell short of estimates, and its full-year EPS guidance of $1.70–$2.10 came in below street expectations of approximately $2.33. This led to mixed analyst reactions and a consensus "Hold" rating, with the stock opening at $19.06 after closing at $20.75.
Edgewell Personal Care Q1 2026 Earnings Call Insights
Edgewell Personal Care's Q1 2026 earnings call highlighted its strategic transformation with the sale of its Feminine Care business, focusing on core categories. The company demonstrated strong North American performance driven by Sun Care orders and effective cost control despite a decline in gross margin. Edgewell projects a stable financial outlook for fiscal 2026, with anticipated adjusted EPS between $1.70 and $2.10 and modest organic net sales growth.
EDGEWELL PERSONAL CARE Co SEC 10-Q Report
Edgewell Personal Care Co (EPC) has released its Q1 fiscal year 2026 10-Q report, detailing a 1.9% increase in net sales to $422.8 million, driven by organic growth in North America. Despite increased sales, the company reported a net loss of $(29.2) million, influenced by a decrease in gross profit and significant restructuring charges. EPC plans to streamline operations, consolidate facilities, and use proceeds from asset sales to invest in core brands and reduce debt.
Edgewell’s Sun Care Sales Soar in Q1
Edgewell Personal Care reported a strong Q1 fiscal 2026, with its sun and skin care unit's organic net sales increasing by 8.0%, primarily driven by a 19.5% growth in sun care, especially in North America. The company also completed the divestiture of its feminine care business, which is expected to positively impact its financial outlook. Overall, Edgewell's Q1 performance exceeded expectations, despite a slight decrease in overall organic net sales.
Edgewell Personal Care (NYSE:EPC) Misses Q4 CY2025 Revenue Estimates
Edgewell Personal Care (NYSE:EPC) reported Q4 CY2025 earnings with consolidated net sales of $486.8 million, exceeding expectations, and a non-GAAP profit of $0.03 per share, significantly beating analyst estimates. However, the company lowered its full-year Adjusted EPS guidance to $1.90 and EBITDA guidance to $255 million, both below analyst expectations. Despite beating EPS, the overall performance was described as mixed, with sales growth struggling historically but analysts projecting a 4.5% revenue increase for the next 12 months.
Edgewell Personal Care Co. Q1 Loss Increases
Edgewell Personal Care Co. (EPC) reported a significant increase in its Q1 loss, posting -$65.7 million compared to -$2.1 million in the previous year, resulting in an EPS of -$1.41. Despite the increased loss, the company's revenue saw a modest rise of 1.9% to $422.8 million. Edgewell has also provided full-year EPS guidance between $1.70 and $2.10 and full-year revenue guidance of 0.5% to 3.5% growth.
Edgewell Q1 Financial Results: Loss, Revenue, and 2026 Earnings Forecast - News and Statistics
Edgewell Personal Care Co. (EPC) reported a fiscal first-quarter loss of $65.7 million, or $1.41 per share, with adjusted losses at 16 cents per share. The company generated $422.8 million in revenue for the period and expects full-year earnings to be between $1.70 and $2.10 per share.
Edgewell Personal: Fiscal Q1 Earnings Snapshot
Edgewell Personal Care Co. (EPC) reported a fiscal first-quarter loss of $65.7 million, or $1.41 per share. Adjusted for discontinued operations and restructuring costs, the loss was 16 cents per share. The consumer products maker recorded revenue of $422.8 million and anticipates full-year earnings between $1.70 and $2.10 per share.
Edgewell Personal Care Company (NYSE:EPC) Receives Average Rating of "Hold" from Analysts
Edgewell Personal Care Company (NYSE:EPC) has received an average "Hold" rating from analysts, with a consensus 12-month price target of $22.67. The company's recent quarterly EPS of $0.68 missed estimates, though revenue slightly exceeded expectations, and several analysts have recently lowered their price targets. Edgewell also pays a quarterly dividend of $0.15, but has a high payout ratio of 115.38%.
Edgewell Personal Care (EPC) Q4 Earnings: What To Expect
Edgewell Personal Care (EPC) is set to report its Q4 earnings this Monday, with analysts expecting flat year-on-year revenue of $478 million and an adjusted loss of -$0.16 per share. The company has a history of missing Wall Street's revenue estimates and is heading into earnings with positive investor sentiment, with its stock up 14% in the last month. Investors will be watching key metrics, especially after a disappointing Q3 where the company missed organic revenue and adjusted operating income estimates.
Edgewell Personal Care (EPC) Q4 Results: Anticipated Outcomes
Edgewell Personal Care (NYSE:EPC) is set to release its Q4 earnings report, with analysts anticipating steady revenue at $478 million and an adjusted loss of -$0.16 per share. The company previously reported a 3.8% revenue increase but missed expectations for organic revenue and adjusted operating income. Despite past misses on Wall Street revenue projections, EPC's stock has outperformed its sector, rising 14% in the last month.
Edgewell Personal Care (EPC) Q4 Earnings: What To Expect
Edgewell Personal Care (EPC) is set to report its Q4 earnings, with analysts expecting revenue to be flat year-on-year at $478 million and an adjusted loss of -$0.16 per share. The company missed revenue estimates in six of the last eight quarters, despite average positive sentiment in the personal care segment. Investors are looking to see how it performs compared to peers e.l.f. Beauty and Estée Lauder, which recently reported their Q4 results.
Analysts’ Top Consumer Goods Picks: Darling Ingredients (DAR), Edgewell Personal Care (EPC)
Analysts from Bank of America Securities, RBC Capital, and Goldman Sachs have issued bullish ratings for several consumer goods companies. Darling Ingredients (DAR) received a Buy rating with a $60.00 price target, Edgewell Personal Care (EPC) also got a Buy rating with a $23.00 price target, and The Hershey Company (HSY) maintained a Buy rating with a $267.00 price target. These recommendations highlight positive outlooks for these companies within the consumer goods sector.
Edgewell Completes Feminine Care Divestiture to Essity
Edgewell Personal Care (EPC) has finalized the sale of its Feminine Care business to Essity for approximately $340 million, a transaction completed on February 2, 2026. The company intends to use the proceeds to reduce debt and reinvest in its core shave, sun, and skin care brands. This divestiture is part of Edgewell's strategy to simplify its portfolio and sharpen its strategic focus, with ongoing transition services provided to Essity for at least one year.
Essity completes the acquisition of Edgewell’s feminine care business
Hygiene and health company Essity has finalized its acquisition of Edgewell Personal Care's feminine care business, including brands like Carefree, Stayfree, o.b., and the global feminine care rights for Playtex, for USD 340 million. This acquisition, which includes a production facility in Delaware, strengthens Essity's market position in North America and aligns with its strategy to grow in high-margin categories. The operations will be consolidated into Essity's accounts as of February 2, 2026.
Shelton’s Edgewell Personal Care completes $340M sale
Edgewell Personal Care Co., based in Shelton, has finalized the sale of its feminine care business, including brands like Playtex and Stayfree, to Sweden's Essity for $340 million. This strategic move aims to reduce debt and strengthen Edgewell's focus on its core businesses such as shave, sun and skin care, and grooming. The company expects to incur some overhead costs in fiscal 2026, largely offset by income from transition support services provided to Essity.
Essity completes acquisition of Carefree, Stayfree and o.b. in US$340 million deal with Edgewell
Essity has finalized its US$340 million all-cash acquisition of Edgewell Personal Care's feminine hygiene business. This deal includes the Carefree, Stayfree, and o.b. brands in North America, global rights to the Playtex feminine hygiene products, and a manufacturing facility in Dover, Delaware. The acquisition reinforces Essity's strategy to expand into higher-margin categories and strengthen its presence in the North American hygiene market.
Edgewell Personal Care completes the sale of its feminine care business
Edgewell Personal Care has finalized the sale of its feminine hygiene business to Swedish company Essity for USD 340 million. This divestment includes the Carefree, Stayfree, o.b., and Playtex brands. Edgewell plans to use the proceeds to strengthen its balance sheet, reduce debt, and focus on its core shave, sun and skin care, and grooming businesses.
Edgewell Sells Feminine Care Business to Essity
Edgewell Personal Care has completed the sale of its feminine care business to Essity for US$340 million, aiming to reduce debt and focus on core categories like shaving and skin care. This divestment aligns with a broader industry trend of streamlining portfolios and will allow Edgewell to strengthen its balance sheet and reinvest in strategic brands. Essity’s acquisition positions it for growth in the feminine intimate care market, which is projected to reach US$14 billion by 2034, driven by rising awareness and consumer preferences.
Essity completes acquisition of Edgewell’s feminine care business
Essity has completed its acquisition of Edgewell Personal Care’s feminine care business, including the Carefree, Stayfree, o.b. brands in North America, and global feminine care rights for the Playtex brand for $340 million. This acquisition supports Essity's strategy to focus on high-margin categories and grow market positions in the United States. The operations were consolidated into Essity's accounts as of February 2, 2026.
Essity Buys Edgewell's Feminine Care Business (Carefree, Stayfree, o.b., Playtex)
Essity has completed its $340 million acquisition of Edgewell Personal Care Co.'s feminine care portfolio, including brands like Carefree, Stayfree, o.b., and Playtex. This move aims to strengthen Essity's personal care business in North America and allows Edgewell to refocus on core brands and debt reduction. The deal expands Essity's presence in the feminine care category and includes a transition period for IT, supply chain, and sales support from Edgewell.
